Achievements and Challenges upon the Implementation of a Program for National Control of Congenital Chagas in Bolivia: Results 2004-2009

PLoS Neglected Tropical Diseases

Volumn 7, Issue 7, 2013, Pages

  Alonso Vega, Cristina ^a,b   Billot, Claire ^a   Torrico, Faustino ^b  

^a Programa Nacional de Control de Chagas Ministry of Health   (Bolivia)

^b UNIVERSIDAD MAYOR DE SAN SIMÓN   (Bolivia)

Author keywords

[No Author keywords available]

Indexed keywords

BENZNIDAZOLE;

ARTICLE; BOLIVIA; CHAGAS DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEALTH PROGRAM; HEMAGGLUTINATION TEST; HUMAN; INFANT; MONITORING; NEWBORN; PREGNANT WOMAN; SEROLOGY;

EID: 84880834288     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002304     Document Type: Article

References (54)

1. WHO (2002) WHO Expert Committee on the Control of Chagas Disease (2000: Brasilia, Brazil). Data WLC-i-P, editor. Control of Chagas disease: second report of the WHO expert committee. 1-109.
2. Pan American Health Organization, WHO Program on Neglected Tropical Diseases (2007) Estimación cuantitativa de la enfermedad de Chagas en las Américas [In Spanish]. Washington, Pan American Health Organization. (OPS/HDM/CD/425-06).
3. Schmunis GA, Yadon ZE, (2010) Chagas disease: a Latin American health problem becoming a world health problem. Acta Tropica 115: 14-21.
4. Lucas RM, Barba MC, (2009) Prevalence of american trypanosomiasis in pregnant women from a health area of Valencia, Spain: 2005-2007. Revista Espanola de Salud Pública 83: 543-555.
5. Dejour Salamanca D, La Ruche G, Tarantola A, Degail MA, Jeannel D, et al. (2009) Chagas disease in France: estimated number of infected persons and cardiac diseases in 2009, by risk groups. Bulletin de la Societe de Pathologie Exotique 102: 285-290.
6. Gonzalez-Granado LI, Rojo-Conejo P, Ruiz-Contreras J, Gonzalez-Tome MI, (2009) Chagas disease travels to Europe. Lancet 373: 2025.
7. Schmunis GA, (2007) Epidemiology of Chagas disease in non-endemic countries: the role of international migration. Memorias do Instituto Oswaldo Cruz 102 Suppl 1: 75-85.
8. Freilij HAJ, Storino R, (1994) Chagas congéinto. In: Storino R MJ, editor. Enfermedad de Chagas. Buenos Aires: Doyma. pp. 267-278.
9. Gomes YM, Lorena VM, Luquetti AO, (2009) Diagnosis of Chagas disease: what has been achieved? What remains to be done with regard to diagnosis and follow up studies? Memorias do Instituto Oswaldo Cruz 104 Suppl 1: 115-121.
10. Martinez de Tejada B, Jackson Y, Paccolat C, Irion O, (2009) Congenital Chagas disease in Geneva: diagnostic and clinical aspects. Revue Medicale Suisse 5: 2091-2092, 2094-2096.
11. Brutus L, Santalla JA, Salas NA, Schneider D, Chippaux JP, (2009) Screening for congenital infection by Trypanosoma cruzi in France. Bulletin de la Societe de Pathologie Exotique 102: 300-309.
12. Chagas disease: a neglected emergency. (2009) The Lancet,Vol 373, DOI: 10.1016/S0140-6736 (09)61002-3.
13. Flores-Chavez M, Faez Y, Olalla JM, Cruz I, Garate T, et al. (2008) Fatal congenital Chagas' disease in a non-endemic area: a case report. Cases Journal 1: 302.
14. Neto EC, Rubin R, Schulte J, Giugliani R, (2004) Newborn screening for congenital infectious diseases. Emerging Infectious Diseases 10: 1068-1073.
15. Jackson Y, Myers C, Diana A, Marti HP, Wolff H, et al. (2009) Congenital transmission of Chagas disease in Latin American immigrants in Switzerland. Emerging Infectious Diseases 15: 601-603.
16. Luquetti AO, Dias JC, Prata A, (2005) Diagnosis and treatment of congenital infection caused by Trypanosoma cruzi in Brazil. Revista da Sociedade Brasileira de Medicina Tropical 38 Suppl 2: 27-28.
17. Zaidenberg M, (1999) Congenital Chagas' disease in the province of Salta, Argentina, from 1980 to 1997. Revista da Sociedade Brasileira de Medicina Tropical 32: 689-695.
18. Sosa-Estani S, (2005) Congenital transmission of Trypanosoma cruzi infection in Argentina. Revista da Sociedade Brasileira de Medicina Tropical 38 Suppl 2: 29-32.
19. Sanchez Negrette O, Mora MC, Basombrio MA, (2005) High prevalence of congenital Trypanosoma cruzi infection and family clustering in Salta, Argentina. Pediatrics 115: e668-672.
20. Blanco SB, Segura EL, Cura EN, Chuit R, Tulian L, et al. (2000) Congenital transmission of Trypanosoma cruzi: an operational outline for detecting and treating infected infants in north-western Argentina. Tropical Medicine & International Health 5: 293-301.
21. de Andrade AL, Zicker F, Martelli CM, (1994) An epidemiological approach to study congenital Chagas' disease. Cadernos de saude publica/Ministerio da Saude, Fundacao Oswaldo Cruz, Escola Nacional de Saude Publica 10 Suppl 2: 345-351.
22. Schenone H, Gaggero M, Sapunar J, Contreras MC, Rojas A, (2001) Congenital Chagas disease of second generation in Santiago, Chile. Report of two cases. Revista do Instituto de Medicina Tropical de Sao Paulo 43: 231-232.
23. Cusnaider CMGRD, Amat L, Aguiló F, Hernández A, Lailla JM (2004) Chagas congénito ¿Es posible en España? Ginecología y Obstertricia Clínica. pp. 198-203. Available: http://www.nexusediciones.com/pdf/gine2004_4/gi-5-4-003.pdf.
24. Munoz J, Coll O, Juncosa T, Verges M, del Pino M, et al. (2009) Prevalence and vertical transmission of Trypanosoma cruzi infection among pregnant Latin American women attending 2 maternity clinics in Barcelona, Spain. Clinical Infectious Diseases 48: 1736-1740.
25. Azogue E, La Fuente C, Darras Ch, (1981) Transmisión Congénita de la Enfermedad de Chagas en Santa Cruz-Bolivia-I-Epidemiología. Bol Inf CENETROP II: 23-29.
26. Azogue E, La Fuente C, Darras C, (1985) Congenital Chagas' disease in Bolivia: epidemiological aspects and pathological findings. Transactions of the Royal Society of Tropical Medicine and Hygiene 79: 176-180.
27. Azogue E, Darras C, (1995) Congenital Chagas in Bolivia: comparative study of the effectiveness and cost of diagnostic methods. Revista da Sociedade Brasileira de Medicina Tropical 28: 39-43.
28. Torrico F, Alonso-Vega C, Suarez E, Rodriguez P, Torrico MC, et al. (2004) Maternal Trypanosoma cruzi infection, pregnancy outcome, morbidity, and mortality of congenitally infected and non-infected newborns in Bolivia. The American Journal of Tropical Medicine and Hygiene 70: 201-209.
29. Chagas en Bolivia. El trabajo del Programa Piloto de Control de Chagas SNS/CCH. (1994) Agencia Internacional de Desarrollo de los EEUU en Bolivia, P.L.480.
30. Congenital infection with Trypanosoma cruzi: from mechanisms of transmission to strategies for diagnosis and control. Revista da Sociedade Brasileira de Medicina Tropical 36: 767-771.
31. Carlier Y, Torrico F, (2005) Coloquio Internacional Infección congénita por Trypanosoma cruzi:desde los mecanismos de transmisión hasta una estrategia de diagnóstico y control. Revista da Sociedade Brasileira de Medicina Tropical 38: 114-118.
32. PAHO (2004) PAHO Consultation on Congenital Chagas Disease, Its Epidemiology and Management OPS/DPC/CD/301/04.
33. Torrico F, Alonso-Vega C, Suarez E, Billot C, Torrico M, et al. (2007) Chagas congénito: Estrategias de Diagnóstico y Control. Ministerio de Salud y Deportes PNdC, editor. Cochabamba, Bolivia.
34. Feilij H, Muller L, Gonzalez Cappa SM, (1983) Direct micromethod for diagnosis of acute and congenital Chagas' disease. Journal of Clinical Microbiology 18: 327-330.
35. Woo PT, (1971) Evaluation of the haematocrit centrifuge and other techniques for the field diagnosis of human trypanosomiasis and filariasis. Acta Tropica 28: 298-303.
36. Torrico MC, Solano M, Guzman JM, Parrado R, Suarez E, et al. (2005) Estimation of the parasitemia in Trypanosoma cruzi human infection: high parasitemias are associated with severe and fatal congenital Chagas disease. Revista da Sociedade Brasileira de Medicina Tropical 38 Suppl 2: 58-61.
37. Suarez E, Alonso-Vega C, Torrico F, Cordova M, (2005) Integral treatment of congenital Chagas disease: the Bolivian experience. Revista da Sociedade Brasileira de Medicina Tropical 38 Suppl 2: 21-23.
38. el Bouhdidi A, Truyens C, Rivera MT, Bazin H, Carlier Y, (1994) Trypanosoma cruzi infection in mice induces a polyisotypic hypergammaglobulinaemia and parasite-specific response involving high IgG2a concentrations and highly avid IgG1 antibodies. Parasite Immunology 16: 69-76.
39. Fescina RHBB, De Mucio B, Martínez G, Díaz Rossello JL, Camacho V, Simini F, Mainero L, (2007) Sistema informático perinatal. Historia Clínica perinatal; Instrucciones de llenado y definición de términos. Montevideo.
40. Rojas Cortez M, Avalos M, Rocha V, Goria D. (2007) Distribución geográfica de los Triatominos en Bolivia: discriminación de la distribución de las especies en relación a variables ambientales. In: Ministerio de Salud y Deportes PNdC, editor. Triatominos de Bolivia y la enfermedad de Chagas. Bolivia. pp. 67-139.
41. Ministerio de Salud y Deportes, Dirección de Planificación y Cooperación externa (2006) Situación de Salud en Bolivia 2004.Documentos de Divulgación Científica.
42. Torrico F, Alonso-Vega C, Billot C, Truyens C, Carlier Y, (2007) Relaciones materno-fetales en la infección con T. cruzi y la implementación de un programa nacional de detección y tratamiento de Chagas congénito en Bolivia. Enfermedades Emergentes 9: 9-16.
43. Chippaux JP, Postigo JR, Santalla JA, Schneider D, Brutus L, (2008) Epidemiological evaluation of Chagas disease in a rural area of southern Bolivia. Transactions of the Royal Society of Tropical Medicine and Hygiene 102: 578-584.
44. Salas NA, Cot M, Schneider D, Mendoza B, Santalla JA, et al. (2007) Risk factors and consequences of congenital Chagas disease in Yacuiba, south Bolivia. Tropical Medicine & International Health 12: 1498-1505.
45. De Rissio AM, Riarte AR, Garcia MM, Esteva MI, Quaglino M, et al. (2010) Congenital Trypanosoma cruzi infection. Efficacy of its monitoring in an urban reference health center in a non-endemic area of Argentina. The American Journal of Tropical Medicine and Hygiene 82: 838-845.
46. Schijman A (2007) Congenital Chagas Disease In: Mushahwar IK, editor. Congenital and Other Related Infectious Diseases of the Newborn: Elsevier B.V. pp. 223-258.
47. Bern C, Verastegui M, Gilman RH, Lafuente C, Galdos-Cardenas G, et al. (2009) Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia. Clinical Infectious Diseases 49: 1667-1674.
48. Ferrel M, (1996) Evolución Epidemiológica de la Tuberculosis en Bolivia. Archivos Bolivianos de Historia de la Medicina 2: 125-129.
49. Ministerio de Salud y Deporte (2008) Anuario 2008. Linea de base de la Estrategia Integral e Intersectorial de Prevención y Control de la Enfermedad de Chagas en Bolivia 2008-2015. La Paz: Ministerio de Salud y Deporte. Programa Nacional de Chagas.
50. Pinazo MJ, Guerrero L, Posada E, Rodriguez E, Soy D, et al. (2013) Benznidazole-related adverse drug reactions and their relationship to serum drug concentrations in patients with chronic chagas disease. Antimicrobial Agents and Chemotherapy 57: 390-395.
51. Viotti R, Vigliano C, Lococo B, Alvarez MG, Petti M, et al. (2009) Side effects of benznidazole as treatment in chronic Chagas disease: fears and realities. Expert Review of Anti-infective Therapy 7: 157-163.
52. Chippaux JP, Clavijo AN, Santalla JA, Postigo JR, Schneider D, et al. (2010) Antibody drop in newborns congenitally infected by Trypanosoma cruzi treated with benznidazole. Tropical Medicine & International Health 15: 87-93.
53. Murcia L, Carrilero B, Munoz-Davila MJ, Thomas MC, Lopez MC, et al. (2013) Risk factors and primary prevention of congenital chagas disease in a nonendemic country. Clinical Infectious Diseases 56: 496-502.
54. Sicuri E, Munoz J, Pinazo MJ, Posada E, Sanchez J, et al. (2011) Economic evaluation of Chagas disease screening of pregnant Latin American women and of their infants in a non endemic area. Acta Tropica 118: 110-117.